Compare SYNA & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYNA | AXGN |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2001 | 2013 |
| Metric | SYNA | AXGN |
|---|---|---|
| Price | $137.24 | $39.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $100.78 | $42.33 |
| AVG Volume (30 Days) | ★ 1.0M | 704.5K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $663,588,000.00 | $225,208,000.00 |
| Revenue This Year | $12.63 | $20.57 |
| Revenue Next Year | $9.67 | $16.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.04 | 20.21 |
| 52 Week Low | $58.06 | $9.22 |
| 52 Week High | $149.11 | $45.83 |
| Indicator | SYNA | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 67.01 | 44.82 |
| Support Level | $65.25 | $30.30 |
| Resistance Level | N/A | $39.99 |
| Average True Range (ATR) | 8.97 | 1.65 |
| MACD | 0.60 | -0.57 |
| Stochastic Oscillator | 73.68 | 7.11 |
Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.